Advancing cancer care through foundational research and immunotherapy

Breakthroughs in cancer care often begin long before a therapy reaches patients. Foundational research into disease biology, cellular mechanisms and immune system function continues to drive innovations that are transforming how cancer is understood and treated. In this episode of Healthcare Insider, Shannon Mortland sits down with Dr. Siddharth Balachandran, PhD, of Temple Health's Fox Chase Cancer Center, to discuss the scientific discoveries helping fuel the future of cancer immunotherapy. The conversation explores how research into influenza viruses and cell death pathways contributed to advances in immunology, why foundational science remains critical to clinical innovation, and how today's laboratory discoveries are informing tomorrow's cancer treatments. What You'll Learn How foundational research helps drive breakthroughs in cancer care The connection between influenza research and advances in immunology Why basic science remains essential to developing new therapies How immune system discoveries are influencing cancer immunotherapy The role of translational research in bringing innovations from the lab to patients What emerging research may mean for the future of cancer treatment and clinical trials